The Effect of narrative writing on depression, anxiety and stress

Not Applicable

Recruiting

• Conditions: Condition 1: depression. Condition 2: anxiety. Condition 3: stress.; Major depressive disorder, single episode, mild; Generalized anxiety disorder; Adjustment disorders

• Registration Number: IRCT20170815035722N2
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

Pregnant women with gestational age between 25 and 28 weeks
age between 18 and 45 years old
Having literacy and ability to read and write
Not taking drugs that cause depression (such as Anti-epileptic drugs, Anti hypertensive drugs, Corticosteroids, Digoxin, Diuretics, Potent tranquilizers, Anti-Parkinson agents)
Singleton pregnancy
Being Primiparous
Having a telephone number
Wanted pregnancy
Earning score of 10-17 (mild depression) from Beck Depression questionnaire
mild depression, mild to medium anxiety, mild to medium stress from DASS21 questionnaire

Exclusion Criteria

Change of location
Stressful events during the study (Death of a close Relative, spouse, newborn, economic problems, marital problems and divorce)
Intrauterine Fetal Death in current pregnancy
preterm laber
Death of mother
Unwillingness to continue the study for any reason
Narrative writing less than twice a week
Having chronic illness
Having diseases that cause depression (such as Epilepsy, Migraine, Multiple Sclerosis)
Taking psychotropic drugs (Opium, Crack, Heroin, Cigarette)
Fetal Anomaly in current oregnancy
Abortion history

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Depression. Timepoint: Before intervention, 4 weeks after intervention, 8 weeks after intervention. Method of measurement: DASS21 Questionnaire (depression-anxiety and stress).;Anxiety. Timepoint: Before intervention, 4 weeks after intervention, 8 weeks after intervention. Method of measurement: DASS21 questionnaire (depression-anxiety and stress).;Stress. Timepoint: Before intervention, 4 weeks after intervention, 8 weeks after intervention. Method of measurement: DASS21 questionnaire (depression-anxiety and stress).